Embecta Corp.
NMS: EMBCLive Quote
📈 ZcoreAI Score
Our AI model analyzes Embecta Corp.'s price action across multiple timeframes using regression channels and statistical scoring.
Get EMBC Z-Score →About Embecta Corp.
Healthcare
Medical Instruments & Supplies
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
📊 Fundamental Analysis
Embecta Corp. demonstrates a healthy profit margin of 12.9%.
The company recently reported -0.3% revenue growth, which is negative, indicating a recent decline in revenue.
At a current price of $8.85, EMBC currently trades near the bottom of its 52-week range (5%), indicating potential value or weakness (Range: $8.47 - $15.55).
💰 Valuation Insight
EMBC trades at a 85.0% discount (PE: 3.75), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
⚠️
Profit Margin
Moderate
🔴
Revenue Growth
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$524.10M
Trailing P/E
3.75
Forward P/E
3.07
Beta (5Y)
1.10
52W High
$15.55
52W Low
$8.47
Avg Volume
854K
Day High
Day Low